Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myelogenous Leukemia, Adult”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01842139
What this trial is testing

Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+4 more
University of Chicago 7
Very early researchLooking for participantsNCT06398457
What this trial is testing

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Who this might be right for
Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Early research (Phase 1)Looking for participantsNCT06366789
What this trial is testing

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
AML With Gene Mutations
Lomond Therapeutics Holdings, Inc. 150
Large-scale testing (Phase 3)Study completedNCT00931138
What this trial is testing

Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2

Who this might be right for
Acute Myeloid Leukemia
Acute Leukemia French Association 420
Early research (Phase 1)Active Not RecruitingNCT05001828
What this trial is testing

Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia, Adult
Polaris Group 38
Early research (Phase 1)Study completedNCT02782468
What this trial is testing

Pevonedistat in Adult East Asian Participants

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Millennium Pharmaceuticals, Inc. 23
Early research (Phase 1)Study completedNCT00125840
What this trial is testing

Clofarabine in Adult Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsLeukemia, Lymphocytic, Acute, PediatricLeukemia, Lymphocytic, Acute, Adult+3 more
Genzyme, a Sanofi Company
Large-scale testing (Phase 3)Looking for participantsNCT04168502
What this trial is testing

Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 414
Post-approval studies (Phase 4)Study completedNCT00180102
What this trial is testing

AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years

Who this might be right for
Leukemia, Nonlymphocytic, Acute
Technische Universität Dresden 600
Not applicableWithdrawnNCT06362031
What this trial is testing

Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Venetoclax Through Chart Review

Who this might be right for
Acute Myeloid Leukemia
AbbVie
Testing effectiveness (Phase 2)Study completedNCT00462605
What this trial is testing

MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+25 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00005854
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT04679194
What this trial is testing

Study of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCT

Who this might be right for
AML/MDS
Mana Therapeutics 11
Early research (Phase 1)Ended earlyNCT00577694
What this trial is testing

Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Leukemia
UNC Lineberger Comprehensive Cancer Center 21
Early research (Phase 1)Ended earlyNCT00430443
What this trial is testing

Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML

Who this might be right for
Acute Lymphocytic LeukemiaAcute Myelogenous Leukemia
Callisto Pharmaceuticals 3
Testing effectiveness (Phase 2)WithdrawnNCT01835288
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
Stanford University
Testing effectiveness (Phase 2)Study completedNCT00004061
What this trial is testing

Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer

Who this might be right for
LeukemiaLymphomaOral Complications
Memorial Sloan Kettering Cancer Center 111
Testing effectiveness (Phase 2)Study completedNCT00469859
What this trial is testing

Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 14
Testing effectiveness (Phase 2)Study completedNCT00096096
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT05356169
What this trial is testing

Intensive Therapy Combined With Venetoclax for Adult Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 312
Next Page